In this July 12, 2012, photo, Centrum multivitamins are shown on the packaging line at the Pfizer plant in Montreal. Drugmaker Pfizer’s third-quarter profit falls 14 percent as sales plunge amid increased generic competition to cholesterol fighter Lipitor, long the world's top-selling drug. Its sales dove 71 percent to $749 million. (AP Photo/The Canadian Press, Graham Hughes)

Associated Press
In this July 12, 2012, photo, Centrum multivitamins are shown on the packaging line at the Pfizer plant in Montreal. Drugmaker Pfizer’s third-quarter profit falls 14 percent as sales plunge amid increased generic competition to cholesterol fighter Lipitor, long the world's top-selling drug. Its sales dove 71 percent to $749 million.   (AP Photo/The Canadian Press, Graham Hughes)
In this July 12, 2012, photo, Centrum multivitamins are shown on the packaging line at the Pfizer plant in Montreal. Drugmaker Pfizer’s third-quarter profit falls 14 percent as sales plunge amid increased generic competition to cholesterol fighter Lipitor, long the world's top-selling drug. Its sales dove 71 percent to $749 million. (AP Photo/The Canadian Press, Graham Hughes)
View Comments (0)